CA
CA · CA · CA-DIN-02458020
DOCETAXEL INJECTION
ATC L01CD02
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerBIOLYSE PHARMA CORPORATION
CountryCA (CA)
ATC codeL01CD02
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02458020",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L01CD02",
"schedule": [
"Prescription"
],
"drug_code": "94508",
"strengths": [
"20 MG"
],
"ahfs_class": null,
"substances": [
"DOCETAXEL"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code L01CD02.
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- NLDemotaxel Mono 20 mg/ml, concentraat voor oplossing voor infusieDemo S.A. Pharmaceutical Industry
Access this data programmatically
Query DOCETAXEL INJECTION and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.